The multinational DESTINATION consortium is comprised of seven exceptional partner organisations, with diverse and complementary expertise relating to the field of RNA delivery.

These include several innovative SMEs (Sixfold Bioscience, FutureSynthesis and Explora Biotech) and leading academic institutions (Newcastle, Bonn, Cima and TU/e), from six different countries.

Employing an interdisciplinary approach driven by our combined academic and industrial expertise will showcase the ability to deliver RNA therapies safely, effectively and in a scalable fashion.